{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:02:12Z","timestamp":1790744532400,"version":"4.1.0"},"reference-count":164,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,3,20]],"date-time":"2018-03-20T00:00:00Z","timestamp":1521504000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.00563","type":"journal-article","created":{"date-parts":[[2018,3,20]],"date-time":"2018-03-20T00:32:51Z","timestamp":1521505971000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":268,"title":["Immunological Approaches Towards Cancer and Inflammation: A Cross Talk"],"prefix":"10.3389","volume":"9","author":[{"given":"Xinglong","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shucheng","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,3,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.ajpath.2011.05.031","article-title":"Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell intravasation","volume":"179","author":"Bekes","year":"2011","journal-title":"Am J Pathol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.it.2015.11.008","article-title":"Neutrophils in the tumor microenvironment","volume":"37","author":"Powell","year":"2016","journal-title":"Trends Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1158\/1541-7786.MCR-05-0261","article-title":"Inflammation, a key event in cancer development","volume":"4","author":"Lu","year":"2006","journal-title":"Mol Cancer Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/carcin\/bgp272","article-title":"Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways","volume":"31","author":"Schetter","year":"2010","journal-title":"Carcinogenesis"},{"key":"B6","first-page":"13","article-title":"Inflammatory mediators: parallels between cancer biology and stem cell therapy","volume":"2","author":"Patel","year":"2009","journal-title":"J Inflamm Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nrc1782","article-title":"Paradoxical roles of the immune system during cancer development","volume":"6","author":"De Visser","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/nri1961","article-title":"Interferons, immunity and cancer immunoediting","volume":"6","author":"Dunn","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/bcr1746","article-title":"Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression","volume":"9","author":"DeNardo","year":"2007","journal-title":"Breast Cancer Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"5802","DOI":"10.1158\/1078-0432.CCR-05-0185","article-title":"Role of mononuclear cells and inflammatory cytokines in pancreatic cancer-related cachexia","volume":"11","author":"Martignoni","year":"2005","journal-title":"Clin Cancer Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/bcr554","article-title":"Host microenvironment in breast cancer development: inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions","volume":"5","author":"Ben-Baruch","year":"2002","journal-title":"Breast Cancer Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1172\/JCI118861","article-title":"Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4 (+) TH1-like responses","volume":"98","author":"Berg","year":"1996","journal-title":"J Clin Invest"},{"key":"B14","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/nature01320","article-title":"Points of control in inflammation","volume":"420","author":"Nathan","year":"2002","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","first-page":"x","DOI":"10.1111\/j.0022-202X.2005.23724.x","article-title":"Inflammation and cancer: is the link as simple as we think?","volume":"124","author":"Nickoloff","year":"2005","journal-title":"J Invest Dermatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S0140-6736(81)90585-7","article-title":"Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22 707 men in Taiwan","volume":"318","author":"Beasley","year":"1981","journal-title":"Lancet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/hep.1840210308","article-title":"Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients","volume":"21","author":"Takano","year":"1995","journal-title":"Hepatology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.3949\/ccjm.76.s3.02","article-title":"Risk of hepatocellular carcinoma in hepatitis B and prevention through treatment","volume":"76","author":"Sherman","year":"2009","journal-title":"Cleve Clin J Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1093\/jnci\/djp023","article-title":"Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research","volume":"101","author":"Punturieri","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"B20","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1126\/science.1156995","article-title":"Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica","volume":"320","author":"Dostert","year":"2008","journal-title":"Science"},{"key":"B21","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1056\/NEJMoa066254","article-title":"Effects of bariatric surgery on mortality in Swedish obese subjects","volume":"357","author":"Sj\u00f6str\u00f6m","year":"2007","journal-title":"N Engl J Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"651","DOI":"10.7150\/ijbs.7.651","article-title":"Dual roles of immune cells and their factors in cancer development and progression","volume":"7","author":"Zamarron","year":"2011","journal-title":"Int J Biol Sci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1146\/annurev-immunol-020711-074942","article-title":"Neutrophil function: from mechanisms to disease","volume":"30","author":"Amulic","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1006\/clim.1999.4709","article-title":"Neutrophils from Mycobacterium avium-infected mice produce TNF-\u03b1, IL-12, and IL-1\u03b2 and have a putative role in early host response","volume":"91","author":"Petrofsky","year":"1999","journal-title":"Clin Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1182\/blood-2002-10-3228","article-title":"Rapid recruitment of inflammatory monocytes is independent of neutrophil migration","volume":"102","author":"Henderson","year":"2003","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12967-017-1141-8","article-title":"Immune modulation of some autoimmune diseases: the critical role of macrophages and neutrophils in the innate and adaptive immunity","volume":"15","author":"Navegantes","year":"2017","journal-title":"J Transl Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1126\/science.1198687","article-title":"Innate or adaptive immunity? The example of natural killer cells","volume":"331","author":"Vivier","year":"2011","journal-title":"Science"},{"key":"B28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.coi.2007.02.001","article-title":"Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?","volume":"19","author":"Bui","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10937400701436460","article-title":"Inflammation and lung cancer: roles of reactive oxygen\/nitrogen species","volume":"11","author":"Azad","year":"2008","journal-title":"J Toxicol Environ Health B Crit Rev"},{"key":"B30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.mrrev.2008.03.002","article-title":"Inflammation: gearing the journey to cancer","volume":"659","author":"Kundu","year":"2008","journal-title":"Mutat Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"24564","DOI":"10.18632\/oncotarget.8356","article-title":"Chronic inflammation-associated genomic instability paves the way for human esophageal carcinogenesis","volume":"7","author":"Lin","year":"2016","journal-title":"Oncotarget"},{"key":"B32","first-page":"7444","article-title":"Oxidative stress increases frameshift mutations in human colorectal cancer cells","volume":"61","author":"Gasche","year":"2001","journal-title":"Cancer Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"C148","DOI":"10.1152\/ajpcell.00422.2001","article-title":"Oxidative stress inactivates the human DNA mismatch repair system","volume":"283","author":"Chang","year":"2002","journal-title":"Am J Physiol Cell Physiol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1136\/gut.48.4.526","article-title":"The risk of colorectal cancer in ulcerative colitis: a meta-analysis","volume":"48","author":"Eaden","year":"2001","journal-title":"Gut"},{"key":"B35","first-page":"2727","article-title":"Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies","volume":"29","author":"Triantafillidis","year":"2009","journal-title":"Anticancer Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1016\/j.ejca.2010.07.017","article-title":"Toll-like receptor (TLR) 7 and TLR8 expression on CD133+ cells in colorectal cancer points to a specific role for inflammation-induced TLRs in tumourigenesis and tumour progression","volume":"46","author":"Grimm","year":"2010","journal-title":"Eur J Cancer"},{"key":"B37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.gde.2009.11.004","article-title":"Inflammation and oncogenesis: a vicious connection","volume":"20","author":"Grivennikov","year":"2010","journal-title":"Curr Opin Genet Dev"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1002\/ijc.23173","article-title":"Inflammation and cancer: an ancient link with novel potentials","volume":"121","author":"Perwez Hussain","year":"2007","journal-title":"Int J Cancer"},{"key":"B39","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1134\/S0006297916020024","article-title":"Interleukins 1 and 6 as main mediators of inflammation and cancer","volume":"81","author":"Dmitrieva","year":"2016","journal-title":"Biochemistry (Mosc)"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-9255-11-23","article-title":"Chronic inflammation and cancer: potential chemoprevention through nuclear factor kappa B and p53 mutual antagonism","volume":"11","author":"Pal","year":"2014","journal-title":"J Inflamm"},{"key":"B41","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1172\/JCI11914","article-title":"Therapeutic potential of inhibition of the NF-\u03baB pathway in the treatment of inflammation and cancer","volume":"107","author":"Yamamoto","year":"2001","journal-title":"J Clin Invest"},{"key":"B42","doi-asserted-by":"publisher","first-page":"5785","DOI":"10.1128\/MCB.19.8.5785","article-title":"NF-\u03baB controls cell growth and differentiation through transcriptional regulation of cyclin D1","volume":"19","author":"Guttridge","year":"1999","journal-title":"Mol Cell Biol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1111\/j.1349-7006.2008.00763.x","article-title":"Inflammation and cancer: role of nuclear factor-kappaB activation","volume":"99","author":"Maeda","year":"2008","journal-title":"Cancer Sci"},{"key":"B44","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/cr.2010.177","article-title":"Non-canonical NF-\u03baB signaling pathway","volume":"21","author":"Sun","year":"2011","journal-title":"Cell Res"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1093\/carcin\/bgp127","article-title":"Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability","volume":"30","author":"Colotta","year":"2009","journal-title":"Carcinogenesis"},{"key":"B46","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1080\/03602530600971974","article-title":"Mechanistic studies of the Nrf2-Keap1 signaling pathway","volume":"38","author":"Zhang","year":"2006","journal-title":"Drug Metab Rev"},{"key":"B47","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/b978-0-12-398339-8.00002-1","article-title":"The Keap1-Nrf2 cell defense pathway \u2013 a promising therapeutic target?","volume":"63","author":"Copple","year":"2011","journal-title":"Adv Pharmacol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1042\/bj20030754","article-title":"Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD (P) H: quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence","volume":"374","author":"Paul","year":"2003","journal-title":"Biochem J"},{"key":"B49","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1073\/pnas.0505723102","article-title":"Activation of the Keap1\/Nrf2 pathway for neuroprotection by electrophillic phase II inducers","volume":"103","author":"Satoh","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1172\/JCI200421146","article-title":"Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice","volume":"114","author":"Rangasamy","year":"2004","journal-title":"J Clin Invest"},{"key":"B51","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1365-2443.2010.01473.x","article-title":"Molecular mechanisms of the Keap1\u2013Nrf2 pathway in stress response and cancer evolution","volume":"16","author":"Taguchi","year":"2011","journal-title":"Genes Cells"},{"key":"B52","first-page":"120","article-title":"Molecular mechanism of inflammatory signaling and predominant role of Saposhnikovia divaricata as anti-inflammatory potential","volume":"19","author":"Khan","year":"2013","journal-title":"Nat Prod Sci"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1016\/j.bbagen.2016.05.032","article-title":"Mitogen-activated protein kinases as key players in osmotic stress signaling","volume":"1860","author":"Zhou","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"B54","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3389\/fmicb.2016.00183","article-title":"The mitogen-activated protein kinase (MAPK) pathway: role in immune evasion by trypanosomatids","volume":"7","author":"Soares-Silva","year":"2016","journal-title":"Front Microbiol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1093\/carcin\/bgu134","article-title":"Caught in the cross fire: p53 in inflammation","volume":"35","author":"Cooks","year":"2014","journal-title":"Carcinogenesis"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e0124000","DOI":"10.1371\/journal.pone.0124000","article-title":"Long term effect of curcumin in restoration of tumour suppressor p53 and phase-II antioxidant enzymes via activation of NRF2 signalling and modulation of inflammation in prevention of cancer","volume":"10","author":"Das","year":"2015","journal-title":"PLoS One"},{"key":"B57","doi-asserted-by":"publisher","first-page":"3683","DOI":"10.1007\/s13277-015-4156-x","article-title":"An integrative transcriptomic analysis reveals p53 regulated miRNA, mRNA, and lncRNA networks in nasopharyngeal carcinoma","volume":"37","author":"Gong","year":"2016","journal-title":"Tumor Biol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s12013-015-0574-z","article-title":"Bladder cancer and genetic mutations","volume":"73","author":"Zhang","year":"2015","journal-title":"Cell Biochem Biophys"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40425-015-0053-5","article-title":"New perspective on targeting the tumor suppressor p53 pathway in the tumor microenvironment to enhance the efficacy of immunotherapy","volume":"3","author":"Guo","year":"2015","journal-title":"J Immunother Cancer"},{"key":"B60","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cyto.2015.12.025","article-title":"TC-PTP and PTP1B: regulating JAK\u2013STAT signaling, controlling lymphoid malignancies","volume":"82","author":"Pike","year":"2016","journal-title":"Cytokine"},{"key":"B61","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cyto.2016.06.017","article-title":"JAK-STAT signaling in cancer: from cytokines to non-coding genome","volume":"87","author":"Pencik","year":"2016","journal-title":"Cytokine"},{"key":"B62","first-page":"6517","article-title":"Role of signal transducer and activator of transcription 5 in nucleophosmin\/anaplastic lymphoma kinase-mediated malignant transformation of lymphoid cells","volume":"61","author":"Nieborowska-Skorska","year":"2001","journal-title":"Cancer Res"},{"key":"B63","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1158\/2159-8290.CD-15-0732","article-title":"STAT5 is a key regulator in NK cells and acts as a molecular switch from tumor surveillance to tumor promotion","volume":"6","author":"Gotthardt","year":"2016","journal-title":"Cancer Discov"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-8722-6-88","article-title":"Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics","volume":"6","author":"Akinleye","year":"2013","journal-title":"J Hematol Oncol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1158\/1078-0432.CCR-15-2389","article-title":"Molecular pathways: targeting the PI3K pathway in cancer-BET inhibitors to the rescue","volume":"22","author":"Stratikopoulos","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.12703\/p7-13","article-title":"The phosphoinositide 3-kinase pathway and therapy resistance in cancer","author":"Brown","year":"2015"},{"key":"B67","doi-asserted-by":"publisher","first-page":"4928","DOI":"10.1158\/1078-0432.CCR-10-1210","article-title":"Key role of phosphoinositide 3-kinase class IB in pancreatic cancer","volume":"16","author":"Edling","year":"2010","journal-title":"Clin Cancer Res"},{"key":"B68","doi-asserted-by":"publisher","first-page":"634292","DOI":"10.1155\/2009\/634292","article-title":"CREB: a key regulator of normal and neoplastic hematopoiesis","volume":"2009","author":"Sandoval","year":"2009","journal-title":"Adv Hematol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"E3260","DOI":"10.1073\/pnas.1319176111","article-title":"CRTC1\/MAML2 gain-of-function interactions with MYC create a gene signature predictive of cancers with CREB-MYC involvement","volume":"111","author":"Amelio","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B70","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.cellsig.2013.08.012","article-title":"The gep proto-oncogene G\u03b1 12 mediates LPA-stimulated activation of CREB in ovarian cancer cells","volume":"26","author":"Ha","year":"2014","journal-title":"Cell Signal"},{"key":"B71","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.mcn.2014.04.002","article-title":"Dynorphin up-regulation in the dentate granule cell mossy fiber pathway following chronic inhibition of GluN2B-containing NMDAR is associated with increased CREB (Ser 133) phosphorylation, but is independent of BDNF\/TrkB signaling pathways","volume":"60","author":"Rittase","year":"2014","journal-title":"Mol Cell Neurosci"},{"key":"B72","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1016\/j.ajpath.2014.06.008","article-title":"CREB-induced inflammation is important for malignant mesothelioma growth","volume":"184","author":"Westbom","year":"2014","journal-title":"Am J Pathol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3389\/fnmol.2015.00046","article-title":"A new perspective on the role of the CREB family of transcription factors in memory consolidation via adult hippocampal neurogenesis","volume":"8","author":"Ortega-Mart\u00ednez","year":"2015","journal-title":"Front Mol Neurosci"},{"key":"B74","doi-asserted-by":"publisher","first-page":"35454","DOI":"10.18632\/oncotarget.7721","article-title":"Control of CREB expression in tumors: from molecular mechanisms and signal transduction pathways to therapeutic target","volume":"7","author":"Steven","year":"2016","journal-title":"Oncotarget"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/08977194.2012.752737","article-title":"The way Wnt works: components and mechanism","volume":"31","author":"Saito-Diaz","year":"2013","journal-title":"Growth Factors"},{"key":"B76","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2741\/4214","article-title":"Wnt and the Wnt signaling pathway in bone development and disease","volume":"19","author":"Wang","year":"2014","journal-title":"Front Biosci (Landmark Ed)"},{"key":"B77","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3389\/fphar.2016.00244","article-title":"Promising druggable target in head and neck squamous cell carcinoma: Wnt signaling","volume":"7","author":"Aminuddin","year":"2016","journal-title":"Front Pharmacol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"7486","DOI":"10.3748\/wjg.v22.i33.7486","article-title":"Aberrant regulation of Wnt signaling in hepatocellular carcinoma","volume":"22","author":"Liu","year":"2016","journal-title":"World J Gastroenterol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.gendis.2015.12.004","article-title":"Wnt\/\u03b2-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance","volume":"3","author":"Mohammed","year":"2016","journal-title":"Genes Dis"},{"key":"B80","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/labinvest.2015.144","article-title":"The evolving roles of canonical WNT signaling in stem cells and tumorigenesis: implications in targeted cancer therapies","volume":"96","author":"Yang","year":"2016","journal-title":"Lab Invest"},{"key":"B81","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/ni.3123","article-title":"Control of adaptive immunity by the innate immune system","volume":"16","author":"Iwasaki","year":"2015","journal-title":"Nat Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"B83","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nature04946","article-title":"Intracellular pattern recognition receptors in the host response","volume":"442","author":"Meylan","year":"2006","journal-title":"Nature"},{"key":"B84","first-page":"2490","article-title":"Inflammatory bowel disease related innate immunity and adaptive immunity","volume":"8","author":"Huang","year":"2016","journal-title":"Am J Transl Res"},{"key":"B85","first-page":"61","article-title":"The effector T helper cell triade","volume":"102","author":"Fietta","year":"2009","journal-title":"Riv Biol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.advms.2016.09.001","article-title":"Cells of the innate and adaptive immunity and their interactions in inflammatory bowel disease","volume":"62","author":"Kmie\u0107","year":"2017","journal-title":"Adv Med Sci"},{"key":"B87","doi-asserted-by":"publisher","first-page":"10582","DOI":"10.1038\/ncomms10582","article-title":"Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1\/PD-L1 therapy","volume":"7","author":"Johnson","year":"2016","journal-title":"Nat Commun"},{"key":"B88","first-page":"5267","article-title":"Inhibition of cytolytic T lymphocyte proliferation by autologous CD4+\/CD25+ regulatory T cells in a colorectal carcinoma patient is mediated by transforming growth factor-\u03b2","volume":"62","author":"Somasundaram","year":"2002","journal-title":"Cancer Res"},{"key":"B89","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1158\/2326-6066.CIR-15-0228","article-title":"Gp96-Ig\/costimulator (OX40L, ICOSL or 4-1BBL) combination vaccine improves T-cell priming and enhances immunity, memory and tumor elimination","volume":"4","author":"Fromm","year":"2016","journal-title":"Cancer Immunol Res"},{"key":"B90","doi-asserted-by":"publisher","first-page":"7456","DOI":"10.4049\/jimmunol.166.12.7456","article-title":"The role of T cell subsets and cytokines in the pathogenesis of Helicobacter pylori gastritis in mice","volume":"166","author":"Eaton","year":"2001","journal-title":"J Immunol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/ni1221","article-title":"Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3","volume":"6","author":"Martin","year":"2005","journal-title":"Nat Immunol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"S299","DOI":"10.1016\/S0016-5085(16)31045-9","article-title":"Sa1375 NOD1 expression in gastric epithelial cells is down-regulated by Helicobacter pylori infection through the methylation of its CpG island by DNA methyltransferases","volume":"150","author":"Mikami","year":"2016","journal-title":"Gastroenterology"},{"key":"B93","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.intimp.2016.05.010","article-title":"Resokaempferol-mediated anti-inflammatory effects on activated macrophages via the inhibition of JAK2\/STAT3, NF-\u03baB and JNK\/p38 MAPK signaling pathways","volume":"38","author":"Yu","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"12851","DOI":"10.1074\/jbc.M116.718825","article-title":"The atypical inhibitor of NF-\u03baB, I\u03baB\u03b6, controls macrophage interleukin-10 expression","volume":"291","author":"H\u00f6rber","year":"2016","journal-title":"J Biol Chem"},{"key":"B95","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1007\/s00018-016-2166-5","article-title":"Tumor-associated macrophages and anti-tumor therapies: complex links","volume":"73","author":"Belgiovine","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"B96","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1172\/JCI59643","article-title":"Macrophage plasticity and polarization: in vivo veritas","volume":"122","author":"Sica","year":"2012","journal-title":"J Clin Invest"},{"key":"B97","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cytogfr.2016.03.012","article-title":"Chemokine regulation of neutrophil function in tumors","volume":"30","author":"Bonavita","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"key":"B98","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of tumor-associated neutrophil phenotype by TGF-\u03b2: \u201cN1\u201d versus \u201cN2\u201d TAN","volume":"16","author":"Fridlender","year":"2009","journal-title":"Cancer cell"},{"key":"B99","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.lungcan.2013.03.003","article-title":"Tumor-associated neutrophils and macrophages in non-small cell lung cancer: no immediate impact on patient outcome","volume":"81","author":"Carus","year":"2013","journal-title":"Lung Cancer"},{"key":"B100","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1593\/neo.07871","article-title":"Plasticity in tumor-promoting inflammation: impairment of macrophage recruitment evokes a compensatory neutrophil response","volume":"10","author":"Pahler","year":"2008","journal-title":"Neoplasia"},{"key":"B101","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1002\/ijc.25892","article-title":"Polymorphonuclear granulocytes in human head and neck cancer: enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease","volume":"129","author":"Trellakis","year":"2011","journal-title":"Int J Cancer"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-015-1541-x","article-title":"Differential infiltration of neutrophils in T1-T2 versus T3-T4 oral squamous cell carcinomas: a preliminary study","volume":"8","author":"Caldeira","year":"2015","journal-title":"BMC Res Notes"},{"key":"B103","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrc2628","article-title":"Tumour necrosis factor and cancer","volume":"9","author":"Balkwill","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"B104","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-immunol-032713-120257","article-title":"TGF-\u03b2 activation and function in immunity","volume":"32","author":"Travis","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1530\/ERC-11-0233","article-title":"A novel human Smad4 mutation is involved in papillary thyroid carcinoma progression","volume":"19","author":"D\u2019Inzeo","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"B106","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ceb.2009.01.021","article-title":"Mechanism of TGF-\u03b2 signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition","volume":"21","author":"Heldin","year":"2009","journal-title":"Curr Opin Cell Biol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.2174\/138161212802430521","article-title":"TGF\u03b2 signaling in liver regeneration","volume":"18","author":"Karkampouna","year":"2012","journal-title":"Curr Pharm Des"},{"key":"B108","doi-asserted-by":"publisher","first-page":"ra19","DOI":"10.1126\/scisignal.aad1884","article-title":"TGF-\u03b2 inhibits the activation and functions of NK cells by repressing the mTOR pathway","volume":"9","author":"Viel","year":"2016","journal-title":"Sci Signal"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-016-2191-7","article-title":"The anti-oxidative transcription factor Nuclear factor E2 related factor-2 (Nrf2) counteracts TGF-\u03b21 mediated growth inhibition of pancreatic ductal epithelial cells-Nrf2 as determinant of pro-tumorigenic functions of TGF-\u03b21","volume":"16","author":"Genrich","year":"2016","journal-title":"BMC Cancer"},{"key":"B110","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10875-012-9847-0","article-title":"Cancer-related inflammation","volume":"33","author":"Candido","year":"2013","journal-title":"J Clin Immunol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1084\/jem.184.4.1397","article-title":"Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response","volume":"184","author":"Pasparakis","year":"1996","journal-title":"J Exp Med"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s00595-015-1165-8","article-title":"Clinical relevance of the number of interleukin-17-producing CD 8+ T cells in patients with gastric cancer","volume":"45","author":"Saito","year":"2015","journal-title":"Surg Today"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1158\/1535-7163.MCT-14-0969","article-title":"Blocking IL1\u03b2 pathway following paclitaxel chemotherapy slightly inhibits primary tumor growth but promotes spontaneous metastasis","volume":"14","author":"Voloshin","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"B114","doi-asserted-by":"publisher","first-page":"43","DOI":"10.5662\/wjm.v6.i1.43","article-title":"Oncogenic role of leptin and Notch interleukin-1 leptin crosstalk outcome in cancer","volume":"6","author":"Lipsey","year":"2016","journal-title":"World J Methodol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"2849523","DOI":"10.1155\/2016\/2849523","article-title":"Pleiotropic effects of IL-2 on cancer: its role in cervical cancer","volume":"2016","author":"Valle-Mendiola","year":"2016","journal-title":"Mediators Inflamm"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.4049\/jimmunol.1302365","article-title":"IL-2 induction of Blimp-1 is a key in vivo signal for CD8+ short-lived effector T cell differentiation","volume":"193","author":"Boulet","year":"2014","journal-title":"J Immunol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1158\/0008-5472.CAN-15-2388","article-title":"IL6 trans-signaling promotes KRAS-driven lung carcinogenesis","volume":"76","author":"Brooks","year":"2016","journal-title":"Cancer Res"},{"key":"B118","doi-asserted-by":"publisher","first-page":"18121","DOI":"10.3748\/wjg.v20.i48.18121","article-title":"Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes","volume":"20","author":"Tomasello","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fimmu.2016.00193","article-title":"Breaking free of control: how conventional T cells overcome regulatory T cell suppression","volume":"7","author":"Mercadante","year":"2016","journal-title":"Front Immunol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00018-016-2254-6","article-title":"MicroRNA regulation of macrophages in human pathologies","volume":"73","author":"Wei","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"B121","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1111\/1440-1681.12608","article-title":"Daphnetin inhibits TNF-\u03b1 and VEGF-induced angiogenesis through inhibition of the IKKs\/I\u03baB\u03b1\/NF-\u03baB, Src\/FAK\/ERK1\/2 and Akt signaling pathways","volume":"43","author":"Kumar","year":"2016","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jnci.2016.05.005","article-title":"Expression of cyclooxygenase 2 and vascular endothelial growth factor in gastric carcinoma: relationship with clinicopathological parameters","volume":"28","author":"Hafez","year":"2016","journal-title":"J Egypt Natl Canc Inst"},{"key":"B123","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1158\/0008-5472.CAN-15-1605","article-title":"Intracrine VEGF signaling mediates the activity of prosurvival pathways in human colorectal cancer cells","volume":"76","author":"Bhattacharya","year":"2016","journal-title":"Cancer Res"},{"key":"B124","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.cell.2015.03.030","article-title":"Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential","volume":"161","author":"Sharma","year":"2015","journal-title":"Cell"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1080\/14712598.2016.1214266","article-title":"Cellular immunotherapy for malignant gliomas","volume":"16","author":"Lin","year":"2016","journal-title":"Expert Opin Biol Ther"},{"key":"B126","doi-asserted-by":"publisher","first-page":"e1122158","DOI":"10.1080\/2162402X.2015.1122158","article-title":"Producer T cells: using genetically engineered T cells as vehicles to generate and deliver therapeutics to tumors","volume":"5","author":"Tsai","year":"2016","journal-title":"Oncoimmunology"},{"key":"B127","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/cr.2016.142","article-title":"CRISPR-Cas9-mediated multiplex gene editing in CAR-T cells","volume":"27","author":"Liu","year":"2017","journal-title":"Cell Res"},{"key":"B128","doi-asserted-by":"publisher","first-page":"23128","DOI":"10.18632\/oncotarget.7440","article-title":"Does an NKT-cell-based immunotherapeutic approach have a future in multiple myeloma?","volume":"7","author":"Favreau","year":"2016","journal-title":"Oncotarget"},{"key":"B129","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.imlet.2013.10.002","article-title":"Tumor cells loaded with \u03b1-galactosylceramide promote therapeutic NKT-dependent anti-tumor immunity in multiple myeloma","volume":"156","author":"Hong","year":"2013","journal-title":"Immunol Lett"},{"key":"B130","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/biomedicines4020010","article-title":"Cancer vaccines in ovarian cancer: how can we improve?","volume":"4","author":"Martin Lluesma","year":"2016","journal-title":"Biomedicines"},{"key":"B131","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.coph.2016.06.009","article-title":"A2A adenosine receptor antagonists to weaken the hypoxia-HIF-1\u03b1 driven immunosuppression and improve immunotherapies of cancer","volume":"29","author":"Hatfield","year":"2016","journal-title":"Curr Opin Pharmacol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.cell.2016.05.051","article-title":"Autophagy, inflammation, and immunity: a troika governing cancer and its treatment","volume":"166","author":"Zhong","year":"2016","journal-title":"Cell"},{"key":"B133","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.ccell.2016.04.014","article-title":"CXCR2 inhibition profoundly suppresses metastases and augments immunotherapy in pancreatic ductal adenocarcinoma","volume":"29","author":"Steele","year":"2016","journal-title":"Cancer Cell"},{"key":"B134","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3390\/ijms17060869","article-title":"Mechanism of action and applications of interleukin 24 in immunotherapy","volume":"17","author":"Persaud","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B135","doi-asserted-by":"publisher","first-page":"7341","DOI":"10.1074\/jbc.M106043200","article-title":"Interleukin 24 (MDA-7\/MOB-5) signals through two heterodimeric receptors, IL-22R1\/IL-20R2 and IL-20R1\/IL-20R2","volume":"277","author":"Wang","year":"2002","journal-title":"J Biol Chem"},{"key":"B136","first-page":"5105","article-title":"Melanoma differentiation-associated gene 7\/interleukin (IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptor","volume":"63","author":"Ramesh","year":"2003","journal-title":"Cancer Res"},{"key":"B137","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.4049\/jimmunol.1490019","article-title":"IL-2: the first effective immunotherapy for human cancer","volume":"192","author":"Rosenberg","year":"2014","journal-title":"J Immunol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1111\/bju.13585","article-title":"Validation of VEGFR1 rs9582036 as predictive biomarker in metastatic clear-cell renal cell carcinoma patients treated with sunitinib","volume":"118","author":"Beuselinck","year":"2016","journal-title":"BJU Int"},{"key":"B139","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00281-006-0012-9","article-title":"Inhibition of IL-1, IL-6, and TNF-\u03b1 in immune-mediated inflammatory diseases","volume":"27","author":"M\u00f6ller","year":"2006","journal-title":"Springer Semin Immunopathol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/intimm\/dxq030","article-title":"IL-6: from its discovery to clinical applications","volume":"22","author":"Kishimoto","year":"2010","journal-title":"Int Immunol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.juro.2016.02.3005","article-title":"Immunotherapy for the treatment of urothelial carcinoma","volume":"197","author":"Donin","year":"2017","journal-title":"J Urol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"e017913","DOI":"10.1136\/bmjopen-2017-017913","article-title":"Radical cystectomy (bladder removal) against intravesical BCG immunotherapy for high-risk non-muscle invasive bladder cancer (BRAVO): a protocol for a randomised controlled feasibility study","volume":"7","author":"Oughton","year":"2017","journal-title":"BMJ Open"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2017.12.007","article-title":"Re: radical cystectomy (bladder removal) against intravesical BCG immunotherapy for high-risk non-muscle invasive bladder cancer (BRAVO): a protocol for a randomised controlled feasibility study","author":"Pang","year":"2017","journal-title":"Eur Urol"},{"key":"B144","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2147\/BTT.S140114","article-title":"New frontiers in oncolytic viruses: optimizing and selecting for virus strains with improved efficacy","volume":"12","author":"Lundstrom","year":"2018","journal-title":"Biologics"},{"key":"B145","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1001294","article-title":"Sipuleucel-T immunotherapy for castration-resistant prostate cancer","volume":"363","author":"Kantoff","year":"2010","journal-title":"N Engl J Med"},{"key":"B146","article-title":"Furin-knockdown and GM-CSF-augmented (FANG) cancer vaccine","author":"Nemunaitis","year":"2017"},{"key":"B147","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1158\/1078-0432.CCR-17-1792","article-title":"NY-ESO-1 vaccination in combination with decitabine induces antigen-specific T-lymphocyte responses in patients with myelodysplastic syndrome","volume":"24","author":"Griffiths","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B148","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.nantod.2010.05.001","article-title":"Polymeric nanomedicines for image-guided drug delivery and tumor-targeted combination therapy","volume":"5","author":"Lammers","year":"2010","journal-title":"Nano Today"},{"key":"B149","doi-asserted-by":"publisher","first-page":"12320","DOI":"10.1002\/anie.201403036","article-title":"Engineered nanoparticles for drug delivery in cancer therapy","volume":"53","author":"Sun","year":"2014","journal-title":"Angew Chem Int Ed"},{"key":"B150","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1002\/jcb.22492","article-title":"Apoptosis-inducing effect of garcinol is mediated by NF-\u03baB signaling in breast cancer cells","volume":"109","author":"Ahmad","year":"2010","journal-title":"J Cell Biochem"},{"key":"B151","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.molonc.2010.08.003","article-title":"Targeted nanoagents for the detection of cancers","volume":"4","author":"McCarthy","year":"2010","journal-title":"Mol Oncol"},{"key":"B152","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1477-3155-5-4","article-title":"Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis","volume":"5","author":"Mukherjee","year":"2007","journal-title":"J Nanobiotechnology"},{"key":"B153","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.ejca.2006.01.044","article-title":"Delivering cancer stem cell therapies \u2013 a role for nanomedicines?","volume":"42","author":"Sch\u00e4tzlein","year":"2006","journal-title":"Eur J Cancer"},{"key":"B154","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.bbrc.2015.06.137","article-title":"Effective treatment of glioblastoma requires crossing the blood\u2013brain barrier and targeting tumors including cancer stem cells: the promise of nanomedicine","volume":"468","author":"Kim","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"B155","first-page":"133","article-title":"The role of nanomedicine in cell based therapeutics in cancer and inflammation","volume":"1","author":"Samarasinghe","year":"2012","journal-title":"Int J Mol Cell Med"},{"key":"B156","first-page":"2045","article-title":"Cancer stem cell targets \u2013 a review","volume":"20","author":"Zhang","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0000000000000596","article-title":"Phase I trial of belinostat with cisplatin and etoposide in advanced solid tumors, with a focus on neuroendocrine and small cell cancers of the lung","author":"Balasubramaniam","year":"2018","journal-title":"Anticancer Drugs"},{"key":"B158","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.18632\/oncotarget.23083","article-title":"Cancer preventive effect of recombinant TRAIL by ablation of oncogenic inflammation in colitis-associated cancer rather than anticancer effect","volume":"9","author":"Kim","year":"2018","journal-title":"Oncotarget"},{"key":"B159","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41419-017-0211-4","article-title":"miR-27b-3p inhibits proliferation and potentially reverses multi-chemoresistance by targeting CBLB\/GRB2 in breast cancer cells","volume":"9","author":"Chen","year":"2018","journal-title":"Cell Death Dis"},{"key":"B160","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.canlet.2018.01.061","article-title":"Non-apoptotic cell death in malignant tumor cells and natural compounds","volume":"420","author":"Ye","year":"2018","journal-title":"Cancer Lett"},{"key":"B161","volume-title":"Targeted Nanoparticle Platforms for Selective Photodynamic Therapy of Cancer","author":"Obaid","year":"2013"},{"key":"B162","doi-asserted-by":"publisher","first-page":"212308","DOI":"10.1007\/s00262-018-2123-2","article-title":"Identification of tumor-reactive B cells and systemic IgG in breast cancer based on clonal frequency in the sentinel lymph node","author":"McDaniel","year":"2017","journal-title":"bioRxiv"},{"key":"B163","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/iub.1696","article-title":"Synthetic lethality in DNA repair network: a novel avenue in targeted cancer therapy and combination therapeutics","volume":"69","author":"Bhattacharjee","year":"2017","journal-title":"IUBMB Life"},{"key":"B164","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11538-018-0402-x","article-title":"Micropharmacology: an in silico approach for assessing drug efficacy within a tumor tissue","author":"Karolak","year":"2018","journal-title":"Bull Math Biol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00563\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,20]],"date-time":"2018-03-20T00:32:53Z","timestamp":1521505973000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00563\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,20]]},"references-count":164,"alternative-id":["10.3389\/fimmu.2018.00563"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.00563","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,20]]},"article-number":"563"}}